Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Neele Delfs"'
Autor:
Franzisca Merkofer, Tristan Struja, Neele Delfs, Carlos C. Spagnuolo, Jason F. Hafner, Kevin Kupferschmid, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine A. Blum
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Glucocorticoid (GC)-induced hyperglycemia is a frequent adverse effect in hospitalized patients. Guidelines recommend insulin treatment to a target range of 6–10 mmol/L (108–180 mg/dl), but efficacies of particular regimes hav
Externí odkaz:
https://doaj.org/article/fa3f57aa6dad4fd1b65719d4d9b10825
Autor:
Julia Kempf, Alexander Schmitz, Aline Meier, Neele Delfs, Beat Mueller, Javier Fandino, Philipp Schuetz, Sven Berkmann
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 3334 (2018)
AIMS OF THE STUDY Acromegaly due to a growth hormone-secreting pituitary adenoma is a rare disease with high morbidity if not treated adequately. Using data of the Swiss Pituitary Registry (SwissPit), we studied initial presentation and predictors f
Externí odkaz:
https://doaj.org/article/9fdc1b170802442abaa489f152defe64
Autor:
Claudine A. Blum, Neele Delfs, Ciril Bächli, Thaddäus Muri, Philipp Schuetz, Beat Mueller, Sandra Gafner, Tristan Struja
Publikováno v:
Journal of the Endocrine Society
Introduction: Glucocorticoid (GC)-induced hyperglycemia is a frequent side effect in hospitalized patients. Guidelines recommend treat-to-target treatment between 6-10 mmol/l with insulin, but patient-specific outcome has not been well-studied. Metho
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Un homme âge de 64 ans s’est presente dans le service des urgences, atteint d’un sepsis. Les analyses de sang ont revele, en tant qu’anomalies concomitantes, un TSH de 0,03 mU/l, un fT3 de
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Ein 64-jahriger Mann stellte sich mit einer Sepsis auf der Notfallstation vor. In der Blutentnahme zeigten sich als Nebenbefund ein TSH von 0,03 mU/l, ein fT3 von
Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Autor:
Tristan Struja, Thaddaeus Muri, Claudine A. Blum, Philipp Schuetz, Beat Mueller, Ciril Baechli, Sandra Gafner, Neele Delfs
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 4079, p 4079 (2020)
Journal of Clinical Medicine
Volume 9
Issue 12
Journal of Clinical Medicine
Volume 9
Issue 12
Background: Glucocorticoid (GC)-induced hyperglycemia is a frequent side effect in hospitalized patients. Guidelines recommend treat-to-target treatment between 6&ndash
10 mmol/L (108&ndash
180 mg/dL) with insulin, but data on outcome is sc
10 mmol/L (108&ndash
180 mg/dL) with insulin, but data on outcome is sc